CCDRD AG provides the insight and expertise of scientists, clinicians, regulators, and health economics experts with skills that cover every aspect of the drug development process. In 2005 alone, CCDRD AG's Phase II-IV comprehensive services were delivered in Europe across multiple therapeutic specialties, at a total of approximately 3000 active study sites.
CCDRD AG takes innovative approaches to provide that clean, high-quality data are generated in time and within budget by challenging assumptions about traditional clinical trial design and management. CCDRD AG's eCRO group is commissioned with generating new approaches to improve the product development process through streamlined data flows, application of appropriate technology solutions, and process improvement. Throughout the company, CCDRD AG offices share SOPs regarding the entire organization and network, as well as communications systems in order to ensure high and reliable standards of quality.
In addition to therapeutic experience across multiple therapeutic specialties, CCDRD maintains centers of excellence in study design and clinical development for the following therapeutic specialties: - Oncology
- CNS
- Alzheimers Disease
- Depression
- Infectious Diseases
- Viral infections, e.g. HSV, HPV
- Bacterial infections
- Hormonal
- Premenopausal
- Perimenopausal
- Postmenopausal
- Renal diseases
- Gastrointestinal Disorders
- Morbus Crohn
- Colitis ulcerosa
- Metabolic disorders
- insuline-dependent diabetes
- postmenopausal osteoporosis
- Dermatological disorders
- Herpes labialis, zoster
- Psoriasis
- Mycotic and dermatophytic infections
|
